Resources for health care professionals
From 1 October 2024, you can support your patients can access continuous glucose monitors and insulin pumps. We will update this page with resources for you.
On this page
Update 1 November 2024
Supply status of the FreeStyle Libre 2
The supplier has brought forward the next shipment of FreeStyle Libre 2. It should be available to wholesalers in the week beginning 4 November 2024.
Dispensing of the FreeStyle Libre 3+
Mediray has alerted us to some unusual ordering patterns for the FreeStyle Libre 3+. Please note, the Freestyle Libre 3+ is only funded for people who qualify for insulin pumps. It is only supported if the person has a YpsoPump and the CamAPS FX algorithm. Please dispense the FreeStyle Libre 3+ when a person has a YpsoPump, or a confirmed start date.
Upcoming/on-demand webinars for healthcare professionals:
Podcast and audio file on Diabetes Technology | Goodfellow Unit(external link)
Dexcom Clarity and Interpretation of your Patient's Data Webinars(external link)
- How to share Clarity data
- Stepwise approach to reviewing CGM data on Clarity
- Recommended reports
- Report interpretation
FreeStyle Libre 2 and FreeStyle Libre 3 Plus Virtual On Demand Session(external link)
- Glucose management with the FreeStyle Libre systems
- Accuracy
- Optional glucose alarms setup
- Integration with automated insulin delivery (AID) systems
- Funding eligibility
- Additional resources to support you and your patients.
The Goodfellow Unit webinar about Diabetes technology and bowel screening(external link).
- Dr Tom Wilkinson gives practical guidance for clinicians to maximise the benefits of CGM and interpret CGM data.
The Pharmaceutical Society of New Zealand webinars(external link) in partnership with MediRay and NZMS covering how the Freestyle Libre and Dexcom CGM products work, compatibility with insulin pumps, counselling points, and problem-solving tips and tricks. These webinars are available following registration free for PSNZ members, and for $46.00 (excl GST) for non-members.
Supplier-led training
Dexcom CGMs
Register for the NZMS Education Hub(external link) and the AMSL & NZMS Diabetes resources via myINTERACT(external link) for resources about Dexcom CGM, Tandem t:slim X2 insulin pumps, including webinars, videos, clinical papers, brochures and flyers, patient resources, clinical tips, and upcoming events.
Dexcom health care practitioner events(external link)
Dexcom products and funding(external link)
Dexcom Healthcare Professionals webpage(external link)
Dexcom Healthcare Professional webpage | Useful links and Resources(external link)
FreeStyle CGMs
Register for the myinteract platform via freestyleconnect.co.nz(external link) for information about the FreeStyle Libre CGMs including webinars, e-learning modules, patient resources, clinical papers, educational resources, clinical tips, and upcoming events.
FreeStyle Libre Videos(external link)
FreeStyle Libre 2 and LibreView, the cloud based diabetes management system(external link)
Health Pathways
Health Pathways offers clinical guidance for clinicians at the point of care.
Nationwide Pathways live from 25 September 2024. Regional Pathways will go live after this date.
Supporting people on a MiniMed 770g insulin pumps
We understand from clinical advice we received that there may be some people who cannot transition from their Medtronic insulin pump to an alternative option. There is a form you can fill out to apply for consideration of continued funding through our exceptional circumstances process for these people.
- Diabetes technology alternative brand allowance form [DOCX 82 KB]
Pharmacy brand switch fee
A brand switch fee for the dispensing of CGMs applies from 1 October 2024 to 1 January 2025.
A brand switch fee provides support to pharmacists providing education and counselling to people being dispensed these devices for the first time.
Health New Zealand funds this payment. Pharmac and Health New Zealand will monitor the uptake of devices to understand if this needs to be extended in the future.
Prescription charges
We have been made aware that some pharmacies are charging additional fees for Continuous Glucose Monitoring (CGM) devices. We would like to clarify that CGM devices listed on the Pharmaceutical Schedule are fully funded, meaning that pharmacies should not charge anything more than the prescription co-payment (typically $5).
We encourage pharmacies to contact your wholesalers for clarity on your terms of trade to secure the best possible deals for your business. We also remind you that any additional charges passed on to the patient must be in line with your Integrated Community Pharmacy Services Agreement (ICPSA)(external link).
Contact Health New Zealand(external link) if you have questions about the ICPSA.
Which CGMs for which people
Our suppliers have alerted us to some unusual ordering patterns for CGMs. Please note, only the standalone CGMs are funded for people without an insulin pump. The Dexcom G6 or G7 and the Freestyle Libre 3+ are only funded for people who qualify for insulin pumps.
| CGM | Type |
|---|---|
| Dexcom One+ | Standalone |
| Freestyle Libre 2 | Standalone |
| Dexcom G6 | Works with YpsoPump and Tandem pump |
| Dexcom G7 | Works with Tandem pump only |
| Freestyle Libre 3+ | Works with the YpsoPump (Will work the Tandem pump from July 2025) |
People with a funded Medtronic pump can access the Dexcom G6, G7 or Freestyle Libre 3+ before they move to a different funded pump.